BB/E527098/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom[Grant Number] - Search Results

Year	Number of Results
2007	1
2008	4
2009	8
2010	5
2011	13
2012	12
2013	8
2014	2
2015	1
2021	1
2022	0

1

Neurovascular aspects of skin neurogenic inflammation.

Aubdool AA, Brain SD. Aubdool AA, et al. J Investig Dermatol Symp Proc. 2011 Dec;15(1):33-9. doi: 10.1038/jidsymp.2011.8. J Investig Dermatol Symp Proc. 2011. PMID: 22076325 Free article. Review.

2

The functions of TRPA1 and TRPV1: moving away from sensory nerves.

Fernandes ES, Fernandes MA, Keeble JE. Fernandes ES, et al. Br J Pharmacol. 2012 May;166(2):510-21. doi: 10.1111/j.1476-5381.2012.01851.x. Br J Pharmacol. 2012. PMID: 22233379 Free PMC article. Review.

3

New advances in musculoskeletal pain.

Bove SE, Flatters SJ, Inglis JJ, Mantyh PW. Bove SE, et al. Brain Res Rev. 2009 Apr;60(1):187-201. doi: 10.1016/j.brainresrev.2008.12.012. Epub 2008 Dec 25. Brain Res Rev. 2009. PMID: 19166876 Free PMC article. Review.

4

The regulation of vascular tetrahydrobiopterin bioavailability.

Starr A, Hussein D, Nandi M. Starr A, et al. Vascul Pharmacol. 2013 Mar;58(3):219-30. doi: 10.1016/j.vph.2012.08.002. Vascul Pharmacol. 2013. PMID: 23634439 Free article. Review.

5

Calcitonin gene-related peptide (CGRP) and its role in hypertension.

Smillie SJ, Brain SD. Smillie SJ, et al. Neuropeptides. 2011 Apr;45(2):93-104. doi: 10.1016/j.npep.2010.12.002. Epub 2011 Jan 26. Neuropeptides. 2011. PMID: 21269690 Review.

6

Sensory-nerve-derived neuropeptides: possible therapeutic targets.

Fernandes ES, Schmidhuber SM, Brain SD. Fernandes ES, et al. Handb Exp Pharmacol. 2009;(194):393-416. doi: 10.1007/978-3-540-79090-7_11. Handb Exp Pharmacol. 2009. PMID: 19655113 Review.

7

Intercellular exchange of surface molecules and its physiological relevance.

Brown K, Fidanboylu M, Wong W. Brown K, et al. Arch Immunol Ther Exp (Warsz). 2010 Aug;58(4):263-72. doi: 10.1007/s00005-010-0085-y. Epub 2010 May 28. Arch Immunol Ther Exp (Warsz). 2010. PMID: 20508995 Review.

8

The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis.

Leiper J, Nandi M. Leiper J, et al. Nat Rev Drug Discov. 2011 Apr;10(4):277-91. doi: 10.1038/nrd3358. Nat Rev Drug Discov. 2011. PMID: 21455237 Review.

9

Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug.

Sanderson L, da Silva M, Sekhar GN, Brown RC, Burrell-Saward H, Fidanboylu M, Liu B, Dailey LA, Dreiss CA, Lorenz C, Christie M, Persaud SJ, Yardley V, Croft SL, Valero M, Thomas SA. Sanderson L, et al. PLoS Negl Trop Dis. 2021 Apr 15;15(4):e0009276. doi: 10.1371/journal.pntd.0009276. eCollection 2021 Apr. PLoS Negl Trop Dis. 2021. PMID: 33857146 Free PMC article.

10

Superoxide generation and leukocyte accumulation: key elements in the mediation of leukotriene B₄-induced itch by transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1.

Fernandes ES, Vong CT, Quek S, Cheong J, Awal S, Gentry C, Aubdool AA, Liang L, Bodkin JV, Bevan S, Heads R, Brain SD. Fernandes ES, et al. FASEB J. 2013 Apr;27(4):1664-73. doi: 10.1096/fj.12-221218. Epub 2012 Dec 27. FASEB J. 2013. PMID: 23271050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results